Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 5
2007 9
2008 9
2009 16
2010 18
2011 9
2012 15
2013 12
2014 16
2015 18
2016 20
2017 13
2018 13
2019 12
2020 14
2021 13
2022 16
2023 31
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Vitiligo: A Review.
Bergqvist C, Ezzedine K. Bergqvist C, et al. Among authors: ezzedine k. Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10. Dermatology. 2020. PMID: 32155629 Free article. Review.
Vitiligo.
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Ezzedine K, et al. Lancet. 2015 Jul 4;386(9988):74-84. doi: 10.1016/S0140-6736(14)60763-7. Epub 2015 Jan 15. Lancet. 2015. PMID: 25596811 Review.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. Among authors: ezzedine k. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
Ezzedine K, Peeva E, Yamaguchi Y, Cox LA, Banerjee A, Han G, Hamzavi I, Ganesan AK, Picardo M, Thaçi D, Harris JE, Bae JM, Tsukamoto K, Sinclair R, Pandya AG, Sloan A, Yu D, Gandhi K, Vincent MS, King B. Ezzedine K, et al. J Am Acad Dermatol. 2023 Feb;88(2):395-403. doi: 10.1016/j.jaad.2022.11.005. Epub 2022 Nov 9. J Am Acad Dermatol. 2023. PMID: 36370907 Free article. Clinical Trial.
New discoveries in the pathogenesis and classification of vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. Among authors: ezzedine k. J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. J Am Acad Dermatol. 2017. PMID: 28619550 Review.
Vitamin D and the Skin: An Update for Dermatologists.
Kechichian E, Ezzedine K. Kechichian E, et al. Among authors: ezzedine k. Am J Clin Dermatol. 2018 Apr;19(2):223-235. doi: 10.1007/s40257-017-0323-8. Am J Clin Dermatol. 2018. PMID: 28994020 Review.
Psychosocial Effects of Vitiligo: A Systematic Literature Review.
Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, Pandya AG. Ezzedine K, et al. Am J Clin Dermatol. 2021 Nov;22(6):757-774. doi: 10.1007/s40257-021-00631-6. Epub 2021 Sep 23. Am J Clin Dermatol. 2021. PMID: 34554406 Free PMC article.
Vitiligo.
Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Picardo M, et al. Among authors: ezzedine k. Nat Rev Dis Primers. 2015 Jun 4;1:15011. doi: 10.1038/nrdp.2015.11. Nat Rev Dis Primers. 2015. PMID: 27189851 Review.
235 results